[Control of side-effects of neuroleptics by dihydergot (DHE 45)].
D014150:Antipsychotic Agents; D002317:Cardiovascular Agents; D004087:Dihydroergotamine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D010120:Oxytocics; D014149:Tranquilizing Agents / Q000009:adverse effects*
D014150:Antipsychotic Agents; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D014149:Tranquilizing Agents; D004087:Dihydroergotamine
ERGOT ALKALOIDS/therapeutic use; TRANQUILIZING AGENTS/injurious effects
Uber die Beeinflussung von Nebenerscheinungen im Verlaufe einer Medikation mit Neuroleptika durch Dihydergot (DHE 45).